ADX71441, a novel, potent and selective positive allosteric modulator of the GABAB receptor, shows efficacy in rodent models of overactive bladder

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|171|4|995-1006

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.171, Iss.4, 2014-02, pp. : 995-1006

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABA_A receptor positive allosteric modulator PF‐06372865

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 4, 2018-02 ,pp. : 708-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Carcinogenicity and Chronic Rodent Toxicity of the Selective Progesterone Receptor Modulator Ulipristal Acetate

Current Drug Safety, Vol. 8, Iss. 2, 2013-04 ,pp. : 77-97

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis

By Palacios Santiago

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1553-1563

Informa Healthcare

Access to resources Recommend Favorite

Darifenacin: a selective M₃ muscarinic receptor antagonist for the treatment of overactive bladder

By Smith Phillip P Lai H Henry Appell Rodney A

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 723-732

Future Medicine

Access to resources Recommend Favorite

GABAB receptors in the bladder and bowel: therapeutic potential for positive allosteric modulators?: Commentary on Kalinichev et al., Br J Pharmacol 171: 995–1006

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 18, 2015-09 ,pp. : 4588-4590

John Wiley & Sons Inc

Access to resources Recommend Favorite